ATEMPT 2.0: Adjuvant T-DM1 vs TH
Clinical trial NCT04893109 · RECRUITING
Trial details
- NCT number
- NCT04893109
- Sponsor
- Dana-Farber Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2026-11-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.